Novartis should face claims it paid kickbacks to advertise MS drug, US appeals court docket guidelines

By Jonathan Stempel NEW YORK (Reuters) -A U.S. appeals court docket on Friday revived a whistleblower lawsuit accusing Swiss drugmaker Novartis (SIX:NOVN) of paying unlawful kickbacks to medical doctors to induce them to advertise its blockbuster a number of sclerosis…